You cannot show any evidence that Gartner was involved in the Dignyte merger.
You cannot show any patents for DR-70 other that Radient's current patent that expires in six weeks and their RCE patent application that hasn't been touched by the USPTO.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.